MedTrace Logo

Feasibility Study of Sleep Endoscopy Under Hypnosis in a Sleep Center

NCT05091164 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2021-10-25

No results posted yet for this study

Summary

It is proposed to induce in a obstructive sleep apnea syndrome patient, a hypnotic trance leading to intense muscle relaxation, capable of reproducing in the upper airways (VAS) the muscle relaxation observed in sleep, at the origin of obstructive apnea and snoring. The collapsibility type obtained, classified according to Kezirian, will allow specific management by OAM in the event of predominant anteroposterior stenosis. There are no risks fort the patient. The Drug Induce Sleep endoscopy (DISE) is a fibroscopy of upper aerodigestive tract.

Conditions

  • Drug Induce Sleep Endoscopy
  • Hypnosis
  • Obstructive Sleep Apnea Syndrome

Interventions

PROCEDURE

Drug induce sleep endoscopy of upper aerodigestive tract under hypnosis

Drug induce sleep endoscopy of upper aerodigestive tract under hypnosis.

Sponsors & Collaborators

  • European Clinical Trial Experts Network

    collaborator OTHER

  • Polyclinique Poitiers

    collaborator UNKNOWN

  • Elsan

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-08
Primary Completion
2021-04-08
Completion
2021-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05091164 on ClinicalTrials.gov